Vanessa Tassell
About Vanessa Tassell
Vanessa Tassell serves as the Chief of Staff for Clinical Development at Mirati Therapeutics, a position she has held since 2023. She has extensive experience in clinical science and development, having worked in various leadership roles at Mirati Therapeutics and Pfizer over the past two decades.
Work at Mirati Therapeutics
Vanessa Tassell currently serves as Chief of Staff, Clinical Development at Mirati Therapeutics, a position she has held since 2023. Her tenure at Mirati spans several roles, beginning as Senior Director of Clinical Science from 2013 to 2016, followed by Executive Director of Clinical Science from 2016 to 2018. She then advanced to Vice President of Clinical Science from 2018 to 2021, and subsequently held the role of Vice President of Clinical Development Operations from 2021 to 2023. Throughout her time at Mirati, she has contributed to various clinical development initiatives.
Education and Expertise
Vanessa Tassell earned a Bachelor of Science degree in Psychology from Northeastern University, where she studied from 1988 to 1993. Her educational background provides a foundation for her expertise in clinical development and science, particularly in the oncology sector. This academic experience complements her extensive professional journey in clinical roles across multiple organizations.
Background
Vanessa Tassell began her career in the clinical research field at PAREXEL as a Senior Clinical Research Associate/Line Manager from 1996 to 2000. She then joined Pfizer, where she held various positions, including Regional Monitor Manager - Oncology from 2000 to 2003, Program Manager from 2003 to 2007, Associate Director from 2007 to 2011, and Director of Clinical Oncology from 2011 to 2013. Her diverse experiences in clinical roles have shaped her career in the pharmaceutical industry.
Professional Experience at Pfizer
During her time at Pfizer, Vanessa Tassell held multiple roles that contributed to her professional development. She worked as Regional Monitor Manager - Oncology from 2000 to 2003, followed by Program Manager from 2003 to 2007. She advanced to Associate Director from 2007 to 2011, and later served as Director of Clinical Oncology from 2011 to 2013. These roles provided her with extensive experience in clinical operations and oncology research.